IDH2 and acute myeloid leukemia: Dual inhibition of IDH1/2-mut may be superior to isoform-selective inhibition because isoform switching from IDH1-mut to IDH2-mut, or vice versa, has been reported as a potential mechanism of acquired resistance in AML.